Learn More
Medchemexpress LLC Nx-1607 | 2573775-59-2 | 99.9% | 537.62 | C30H34F3N5O | 5 MG

Supplier: Medchemexpress LLC HY1414325MG
NX-1607 is a first-in-class, orally bioavailable small-molecule inhibitor of the E3 ubiquitin ligase Cbl-b. It exhibits sub-nanomolar potency (IC50 < 1 nM) and is used in preclinical and clinical immuno-oncology research to enhance T-cell activation, reduce exhaustion, and increase antigen recall and cytokine production. Supplied for laboratory research use only.
- Potent sub-nanomolar inhibitory activity against Cbl-b.
- Enhances T-cell activation and antigen recall.
- Reduces T-cell exhaustion and increases cytokine production.
- Orally bioavailable small molecule suitable for in vivo studies.
- High purity solid with white to off-white appearance.
- Stable when stored sealed; follow recommended storage conditions.
- Supplied in small-scale packaging for research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.